← Back to headlines
UBS Lifts Valuation on Moderna Ahead of Key Pipeline Catalysts
UBS has raised its valuation on Moderna, Inc., anticipating key pipeline catalysts that could impact the company's future performance.
2 Jun, 13:55 — 2 Jun, 13:55
Sources
Showing 1 of 1 sources
